CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?
Seong Ran Jeon
Intest Res. 2018;16(2):163-165.   Published online April 30, 2018
DOI: https://doi.org/10.5217/ir.2018.16.2.163

Excel Download

Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?
Intestinal Research. 2018;16(2):163   Crossref logo
Link1 Link2 Link3

Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind study
Intestinal Research. 2017;15(3):358   Crossref logo
Link1 Link2 Link3

Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study
Intestinal Research. 2017;15(3):368   Crossref logo
Link1 Link2 Link3

Is once-daily dosing of mesalazine effective for maintenance of remission in patients with ulcerative colitis?
Nature Clinical Practice Gastroenterology & Hepatology. 2008;5(11):596-597   Crossref logo
Link1 Link2 Link3

Once dailyvsmultiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis
Colorectal Disease. 2016;18(7):O214-O223   Crossref logo
Link1

Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study
Intestinal Research. 2018;16(2):255   Crossref logo
Link1 Link2 Link3

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial
Yearbook of Gastroenterology. 2009;2009:102-103   Crossref logo
Link1 Link2

High-dose mesalazine treatment for ulcerative colitis patients who relapse under low-dose maintenance therapy
Digestive and Liver Disease. 2011;43(5):386-390   Crossref logo
Link1 Link2

Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study
Alimentary Pharmacology and Therapeutics. 2006;24(7):1087-1097   Crossref logo
Link1

Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis
Clinical and Experimental Gastroenterology. 2014;369   Crossref logo
Link1